Atrioventricular block medical therapy

Atrioventricular block Microchapters
Home
Patient Information
Overview
Historical Perspective
Classification
Pathophysiology
Causes
Differentiating Atrioventricular block from other Diseases
Epidemiology and Demographics
Risk Factors
Natural History, Complications and Prognosis
Diagnosis
History and Symptoms
Physical Examination
Laboratory Findings
Electrocardiogram
EKG Examples
Chest X Ray
Echocardiography
Other Diagnostic Studies
Treatment
Medical Therapy
Surgery
Primary Prevention
Secondary Prevention
Cost-Effectiveness of Therapy
Future or Investigational Therapies
Case Studies
Case #1
Atrioventricular block medical therapy On the Web
Most recent articles
Most cited articles
Review articles
CME Programs
Powerpoint slides
Images
American Roentgen Ray Society Images of Atrioventricular block medical therapy All Images X-rays Echo & Ultrasound CT Images MRI
Ongoing Trials at Clinical Trials.gov
US National Guidelines Clearinghouse
NICE Guidance
FDA on Atrioventricular block medical therapy
CDC on Atrioventricular block medical therapy
Atrioventricular block medical therapy in the news
Blogs on Atrioventricular block medical therapy
Directions to Hospitals Treating Atrioventricular block
Risk calculators and risk factors for Atrioventricular block medical therapy

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Aarti Narayan, M.B.B.S [2]

Overview

Treatment goal is to remove the extrinsic causes and treat reversible intrinsic causes. Drugs used in the treatment of AV nodal blocks include atropine, isoproterenol, theophylline, antibiotics treatment for lyme disease and treatment of ischemia. A permanent pacemaker is indicated for symptomatic bradycardia due to advanced second- or third-degree heart blocks.

Medical Therapy

• Permanent pacemaker is the treatment of choice for atrioventricular blocks and does not require concomitant pharmacologic treatment.
• Drugs that block AV nodal conduction must be discontinued.

Emergency Management

• Atropine may be administered in emergency management of atrioventricular block to improve AV conduction until a temporary transcutaneous or transvenous pacemaker is inserted. However, atropine can potentially worsen the conduction if the block is in the bundle of His.

Atropine

• Anti-cholinergic drug
• Improves AV conduction
• Insufficient doses can worsen the block

Isoproterenol

• Isoproterenol is a beta 1 and beta 2 receptor agonist
• Increases heart rate
• Ionotropic effect

Follow-up

• Patients with first degree AV block and Mobitz I can be managed at home and require a continuous follow-up with EKG or Holter monitoring to look for progression to a more severe type of heart block.